We propel biotechs toward financial mastery
Biotechs are the driving force behind new therapies that will cure disease and transform quality of life – but a third of clinical trials fail for reasons unrelated to efficacy or safety. We started Auxilius after hundreds of conversations with experienced Chief Science Officers and CFOs who learned the hard way that clinical R&D is about more than science.
Often overnight, science-led organizations become full-fledged businesses — with outsourced vendors, large budgets, operational complexity, and evolving capital needs. And yet it’s common to ignore financial maturity in pursuit of milestones. We believe that Biotechs can bring drugs to market quickly and cost effectively. We believe that small and mid-sized Sponsors really can have it all — it just takes the right tools. That's why we're here.